Stanley R. Riddell

Stanley Riddell is a pioneer in adoptive T cell therapy who has made foundational contributions to CAR-T cell development. His laboratory has systematically optimized CAR designs, T cell manufacturing protocols, and lymphodepletion regimens to improve clinical outcomes. Riddell's work on defining optimal T cell subsets and CAR signaling domains has directly influenced approved CAR-T products.

Stanley Riddell是过继T细胞治疗的先驱，在CAR-T细胞开发方面做出了基础性贡献。他的实验室系统地优化了CAR设计、T细胞制造方案和淋巴细胞清除方案，以改善临床结果。Riddell在定义最佳T细胞亚群和CAR信号结构域方面的工作直接影响了已批准的CAR-T产品。